Exploring the unique qualities of INGREZZA, the newest FDA-approved drug for Huntington’s disease chorea

Author(s)

Kenneth P. Serbin PhD, University of San DiegoFollow

Document Type

Blog Post

Publication Date

7-12-2024

Digital USD Citation

Serbin, Kenneth P. PhD, "Exploring the unique qualities of INGREZZA, the newest FDA-approved drug for Huntington’s disease chorea" (2024). At Risk for Huntington's Disease. 319.
https://digital.sandiego.edu/huntingtons/319